share_log

德琪醫藥-B：董事會會議日期通告

ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING

香港交易所 ·  Mar 11 04:30
Summary by Moomoo AI
德琪醫藥有限公司（「本公司」）宣佈將於2024年3月22日（星期五）舉行董事會會議，主要目的是考慮並批准公司及其附屬公司截至2023年12月31日止年度的業績及其發佈。董事會成員包括執行董事梅建明博士、John F. Chin先生及龍振國先生；非執行董事陳侃博士；以及獨立非執行董事Rafael Fonseca博士、錢晶女士及唐晟先生。
德琪醫藥有限公司（「本公司」）宣佈將於2024年3月22日（星期五）舉行董事會會議，主要目的是考慮並批准公司及其附屬公司截至2023年12月31日止年度的業績及其發佈。董事會成員包括執行董事梅建明博士、John F. Chin先生及龍振國先生；非執行董事陳侃博士；以及獨立非執行董事Rafael Fonseca博士、錢晶女士及唐晟先生。
DEKI PHARMACEUTICALS CO., LTD. (THE “COMPANY”) ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON FRIDAY, MARCH 22, 2024, THE PRIMARY PURPOSE OF WHICH IS TO CONSIDER AND APPROVE THE RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED DECEMBER 31, 2023 AND THEIR RELEASE. The members of the Board of Directors include Executive Directors Dr. Mei Jianming, Mr. John F. Chin and Mr. Lung Zhenguo; Dr. Chen Yi, Non-Executive Director; and Independent Non-Executive Directors Dr. Rafael Fonseca, Ms. Qian Jing and Mr. Tang Sheng.
DEKI PHARMACEUTICALS CO., LTD. (THE “COMPANY”) ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON FRIDAY, MARCH 22, 2024, THE PRIMARY PURPOSE OF WHICH IS TO CONSIDER AND APPROVE THE RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED DECEMBER 31, 2023 AND THEIR RELEASE. The members of the Board of Directors include Executive Directors Dr. Mei Jianming, Mr. John F. Chin and Mr. Lung Zhenguo; Dr. Chen Yi, Non-Executive Director; and Independent Non-Executive Directors Dr. Rafael Fonseca, Ms. Qian Jing and Mr. Tang Sheng.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more